Professor & patients' paper on the solvable biological challenge of ME/CFS: reader-friendly version
Simon McGrath provides a patient-friendly version of a peer-reviewed paper which highlights some of the most promising biomedical research on ME/CFS ...
Discuss the article on the Forums.

Refractory depression metabolomics study involving RK Naviaux

Discussion in 'Other Health News and Research' started by hixxy, Aug 17, 2016.

  1. hixxy

    hixxy Senior Member

    Messages:
    1,109
    Likes:
    1,277
    Australia
    Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior

    Lisa A. Pan, M.D., Petra Martin, B.S., Thomas Zimmer, B.S., Anna Maria Segreti, B.S., Sivan Kassiff, B.S., Brian W. McKain, R.N., M.S.N., Cynthia A. Baca, R.N., M.S.N., Manivel Rengasamy, M.D., Keith Hyland, Ph.D., Nicolette Walano, M.S., Robert Steinfeld, M.D., Marion Hughes, M.D., Steven K. Dobrowolski, Ph.D., Michele Pasquino, B.S., Rasim Diler, M.D., James Perel, Ph.D., David N. Finegold, M.D., David G. Peters, Ph.D., Robert K. Naviaux, M.D., Ph.D., David A. Brent, M.D., Jerry Vockley, M.D., Ph.D.

    Received: November 29, 2015
    Accepted: May 20, 2016

    Published online: August 13, 2016 | http://dx.doi.org/10.1176/appi.ajp.2016.15111500

    Abstract

    Objective:
    Treatment-refractory depression is a devastating condition with significant morbidity, mortality, and societal cost. At least 15% of cases of major depressive disorder remain refractory to treatment. The authors previously identified a young adult with treatment-refractory depression and multiple suicide attempts with an associated severe deficiency of CSF tetrahydrobiopterin, a critical cofactor for monoamine neurotransmitter synthesis. Treatment with sapropterin, a tetrahydrobiopterin analogue, led to dramatic and long-lasting remission of depression. This sentinel case led the authors to hypothesize that the incidence of metabolic abnormalities contributing to treatment-refractory depression is underrecognized.

    Method:
    The authors conducted a case-control, targeted, metabolomic evaluation of 33 adolescent and young adult patients with well-characterized histories of treatment-refractory depression (at least three maximum-dose, adequate-duration medication treatments), and 16 healthy comparison subjects. Plasma, urine, and CSF metabolic profiling were performed by coupled gas chromatography/mass spectrometry and high-performance liquid chromatography electrospray ionization tandem mass spectrometry.

    Results:
    CSF metabolite abnormalities were identified in 21 of the 33 participants with treatment-refractory depression. Cerebral folate deficiency (N=12) was most common, with normal serum folate levels and low CSF 5-methyltetrahydrofolate (5-MTHF) levels. All patients with cerebral folate deficiency, including one with low CSF levels of 5-MTHF and tetrahydrobiopterin intermediates, showed improvement in depression symptom inventories after treatment with folinic acid; the patient with low tetrahydrobiopterin also received sapropterin. None of the healthy comparison subjects had a metabolite abnormality.

    Conclusions:
    Examination of metabolic disorders in treatment-refractory depression identified an unexpectedly large proportion of patients with potentially treatable abnormalities. The etiology of these abnormalities remains to be determined.

    http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.15111500
     
    HowToEscape?, merylg, Webdog and 9 others like this.
  2. wastwater

    wastwater Senior Member

    Messages:
    914
    Likes:
    617
    uk
    Was looking at sapropterin,seems it works very well for some,worth a bump.
     

See more popular forum discussions.

Share This Page